Literature DB >> 21387168

Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort.

Sinem Ezgi Gulmez1, Cécile Droz-Perroteau, Régis Lassalle, Patrick Blin, Bernard Bégaud, Michel Rossignol, Nicholas Moore, Annie Fourrier-Réglat.   

Abstract

AIM: To describe the inappropriate use of traditional non-steroidal anti-inflammatory drugs (tNSAIDs) in elderly subjects in the CADEUS cohort using the Beers 2003 criteria modified by recommendations from the French Medicines Agency.
METHODS: Of the 23,217 subjects in the CADEUS cohort, 1,851 were ≥65 years old, had bee diagnosed with osteoarthritis (OA), and had been dispensed a tNSAID at least once in the 6 months before the index date. Data were obtained from the French national reimbursement database and from patient and prescriber questionnaires. The Beers criteria for inappropriate use were modified to include all tNSAIDs, and long-term high-dose use was defined as having been dispensed at least five dispensations for tNSAID over a 6-month period with a gap of <45 days between each dispensation and when the gap was >45 days, medicine availability >50% [i.e., defined daily dose (DDD) delivered/theoretical DDD] for the gap.
RESULTS: The most frequently dispensed tNSAIDs were piroxicam (25%), diclofenac (24%), ibuprofen (18%), ketoprofen (18%), and naproxen (10%). Of the study population, 1.5% were dispensed indomethacin; 15%, two tNSAIDs; 15%, a tNSAIDs with a platelet aggregation inhibitor; 4.6%, a tNSAID with low-dose aspirin; 0.2%, a tNSAID with vitamin K antagonists. The analysis revealed that 18% of the study population were high-dose and long-term users of tNSAIDs and that 70% of these were dispensed a proton pump inhibitor.
CONCLUSIONS: The most common inappropriate tNSAID dispensation was the co-prescription of two different tNSAIDs within 1 month or of a platelet aggregation inhibitor. The real-life consequences of our results need to be ascertained, and it would be interesting to update the Beers criteria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21387168     DOI: 10.1007/s00228-011-1015-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.

Authors:  N Moore; X Verschuren; C Montout; J Callens; S X Kong; B Bégaud
Journal:  Therapie       Date:  2000 Jan-Feb       Impact factor: 2.070

2.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

3.  NSAID use profiles derived from reimbursement data in France.

Authors:  Nicholas Moore; Hélène Diris; Karin Martin; Raymond Viale; Annie Fourrier; Yola Moride; Bernard Bégaud
Journal:  Therapie       Date:  2004 Sep-Oct       Impact factor: 2.070

Review 4.  Inappropriate prescribing in the older population: need for new criteria.

Authors:  Denis O'Mahony; Paul Francis Gallagher
Journal:  Age Ageing       Date:  2008-03       Impact factor: 10.668

Review 5.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

Review 6.  Explicit criteria for determining potentially inappropriate medication use by the elderly. An update.

Authors:  M H Beers
Journal:  Arch Intern Med       Date:  1997-07-28

7.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

8.  Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.

Authors:  F Depont; A Fourrier; Y Merlière; C Droz; M Amouretti; B Bégaud; J Bénichou; Y Moride; G P Velo; M Sturkenboom; P Blin; N Moore
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-08       Impact factor: 2.890

Review 9.  Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.

Authors:  Matthias Hermann
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

10.  Place of OTC analgesics and NSAIDs in osteoarthritis.

Authors:  Nicholas Moore
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

View more
  2 in total

Review 1.  Potentially inappropriate medications in the elderly: a comprehensive protocol.

Authors:  Suzana Mimica Matanović; Vera Vlahovic-Palcevski
Journal:  Eur J Clin Pharmacol       Date:  2012-02-24       Impact factor: 2.953

2.  Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital.

Authors:  Hooi Leng Lee; Siew Siang Chua; Sanjiv Mahadeva
Journal:  Ther Clin Risk Manag       Date:  2016-11-10       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.